...
首页> 外文期刊>Journal of Lipid Research >Metabolic phospholipid labeling of intact bacteria enables a fluorescence assay that detects compromised outer membranes[S]
【24h】

Metabolic phospholipid labeling of intact bacteria enables a fluorescence assay that detects compromised outer membranes[S]

机译:完整细菌的代谢磷脂标记使得荧光测定能够检测受损的外膜[S]

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Gram-negative bacteria possess an asymmetric outer membrane (OM) composed primarily of lipopolysaccharides (LPSs) on the outer leaflet and phospholipids (PLs) on the inner leaflet. The loss of this asymmetry due to mutations in the LPS biosynthesis or transport pathways causes the externalization of PLs to the outer leaflet of the OM and leads to OM permeability defects. Here, we used metabolic labeling to detect a compromised OM in intact bacteria. Phosphatidylcholine synthase expression in Escherichia coli allowed for the incorporation of exogenous propargylcholine into phosphatidyl(propargyl)choline and exogenous 1-azidoethyl-choline (AECho) into phosphatidyl(azidoethyl)choline (AEPC), as confirmed by LC/MS analyses. A fluorescent copper-free click reagent poorly labeled AEPC in intact wild-type cells but readily labeled AEPC from lysed cells. Fluorescence microscopy and flow cytometry analyses confirmed the absence of significant AEPC labeling from intact wild-type E. coli strains and revealed significant AEPC labeling in an E. coli LPS transport mutant (lptD4213) and an LPS biosynthesis mutant (E. coli lpxC101). Our results suggest that metabolic PL labeling with AECho is a promising tool for detecting a compromised bacterial OM, revealing aberrant PL externalization, and identifying or characterizing novel cell-active inhibitors of LPS biosynthesis or transport.
机译:革兰氏阴性细菌具有主要由内部传单上的外叶片和磷脂(PLS)上的脂多糖(LPS)组成的不对称外膜(OM)。由于LPS生物合成或输送途径中的突变导致该不对称性的损失导致PLS的外部化到OM的外部叶片,并导致OM渗透性缺陷。在这里,我们使用代谢标记来检测完整细菌中的受损OM。如LC / MS分析证实,磷酰基胆碱在大肠杆菌中掺入磷脂酰胆碱(丙基)胆碱和外源1-β胆碱(AEPC)中的外源炔丙基和外源1-唑烷基乙基 - 胆碱(AECHO)。在完整的野生型细胞中,无荧光无铜点击试剂标记良好的AEPC,但易于溶解细胞标记为APC。荧光显微镜和流式细胞术分析证实不存在来自完整的野生型大肠杆菌菌株的显着AEPC标记,并在大肠杆菌LPS传输突变体(LPTD4213)和LPS生物合成突变体(大肠杆菌LPXC101)中揭示了显着的APC标记。我们的研究结果表明,使用Aecho的代谢PL标记是检测受损细菌OM的有前途的工具,揭示异常PL外化,并鉴定或表征LPS生物合成或运输的新细胞活性抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号